TIMP-1 expression is increased in X-linked progressive retinal atrophy despite its exclusion as a candidate gene

Citation
Cj. Zeiss et al., TIMP-1 expression is increased in X-linked progressive retinal atrophy despite its exclusion as a candidate gene, GENE, 225(1-2), 1998, pp. 67-75
Citations number
25
Categorie Soggetti
Molecular Biology & Genetics
Journal title
GENE
ISSN journal
03781119 → ACNP
Volume
225
Issue
1-2
Year of publication
1998
Pages
67 - 75
Database
ISI
SICI code
0378-1119(199812)225:1-2<67:TEIIIX>2.0.ZU;2-S
Abstract
X-linked progressive retinal atrophy (XLPRA) is the only known natural anim al model for X-linked retinitis pigmentosa (XLRP), a blinding disorder in m an. The tissue inhibitor metalloproteinase 1 gene (TIMP-1), present in clos e proximity to one of the two XLRP loci, was tested as a candidate for XLPR A, by first characterizing the cDNA and gene from a normal dog. The cloned canine TIMP-1 cDNA is predicted to encode a protein of 207 amino acids with 66-83% identity in the deduced aa sequence with homologous mammalian genes . No sequence difference in the coding sequence of TIMP-1 was observed betw een normal and XLPRA-affected dogs. TIMP-1 was found to be expressed in all of the canine tissues examined by reverse transcription and polymerase cha in reaction. The canine TIMP-1 spans 3.5 kb and is interrupted by five intr ons with sizes comparable to those observed in the human and mouse homologu es of the gene. The proximal promoter region of canine TIMP-1 contains sequ ence motifs shown to have regulatory significance in transcription of human TIMP-1. Linkage analysis between XLPRA and TIMP-1 using a newly identified intragenic polymorphism identified recombinants, which conclusively exclud ed the gene as a candidate for the disease. TIMP-1 is overexpressed several months before retinal degeneration is histologically evident in XLPRA dogs , implying that alterations in interphotoreceptor matrix composition preced e retinal degeneration by a significant time period. (C) 1998 Elsevier Scie nce B.V. All rights reserved.